Forward P/E vs Trailing P/E: What the Gap Reveals

Two stocks. Both described as "expensive." One is genuinely overpriced; the other is cheap relative to where its earnings are heading. The difference lives entirely in which P/E ratio you use, and most investors treat the two as interchangeable. They are not.

This post breaks down what each ratio actually measures, why the gap between them matters more than either figure alone, and how to read that gap across real stocks in the current market.

What Each Ratio Measures

Trailing P/E divides the current share price by earnings per share over the last twelve months. It is backward-looking by definition. The earnings figure is audited, reported, and real. No assumptions required.

Forward P/E divides the current share price by the consensus estimate for earnings over the next twelve months. The denominator is a forecast. It reflects what analysts collectively expect the business to earn, not what it has already delivered.

Neither is better in isolation. Together, they tell a story.

The Gap Is the Signal

When forward P/E sits meaningfully below trailing P/E, the market is pricing in earnings growth. Analysts expect the denominator to expand, which compresses the multiple. A wide gap between the two ratios is a quantitative expression of growth expectations baked into the current price.

When forward P/E sits close to, or above, trailing P/E, one of two things is happening: earnings are expected to be flat or declining, or the stock is already priced for perfection with little room for estimates to move higher.

The ratio between the two numbers, not just their absolute levels, is where the analytical work begins.

Real Examples From the Current Market

Look at Astera Labs (ALAB). The trailing P/E sits at 246.4x. Taken alone, that number stops most value-oriented investors cold. But the forward P/E is 87.3x, implying analysts expect earnings to nearly triple over the next twelve months. That expectation is not unfounded: Astera Labs posted 93.4% revenue growth and 144.4% earnings growth year-over-year as of the most recent data. The gap between 246x and 87x is enormous, and it reflects a business in a steep earnings ramp, not a mature company trading at a speculative premium.

Broadcom (AVGO) tells a similar structural story at a different scale. Trailing P/E is 94.5x; forward P/E is 26.3x. That compression from 94x to 26x is one of the largest gaps in the current large-cap technology universe. Broadcom reported 29.5% revenue growth and 31.6% earnings growth year-over-year, and its AI chip revenue recently surged to $10.8 billion with $16 billion guided for the next quarter. The forward multiple of 26.3x looks entirely different from the trailing multiple of 94.5x, and the business fundamentals explain why.

Contrast those two with Reddit (RDDT). Trailing P/E is 48.1x; forward P/E is 19.1x. The gap exists, but it is proportionally smaller than ALAB or AVGO. Reddit grew revenue 69.1% year-over-year and earnings 675%, so the trailing multiple is distorted by a low earnings base. The forward multiple of 19.1x is actually modest for a platform growing at that rate. Here the trailing P/E overstates expensiveness because the earnings base is still small relative to where the business is heading.

Now look at a case where the gap narrows almost to nothing. Target (TGT) trades at a trailing P/E of 16.4x and a forward P/E of 14.0x. The gap is tight. Earnings are expected to grow modestly, not explosively. Year-over-year earnings are actually down 24.7% on a trailing basis, which is why the trailing multiple looks elevated relative to the forward. This is the inverse situation: trailing P/E overstates cheapness because the recent earnings period was weak, while forward P/E reflects a recovery scenario.

Sarepta Therapeutics (SRPT) is the most extreme example in the current data. Trailing P/E is 46.2x; forward P/E is 5.9x. A forward multiple of 5.9x on a biotech is either a deep value opportunity or a sign that analysts expect a dramatic earnings event, such as a major drug approval or royalty stream, to materialize within the next twelve months. The gap here is so wide that it demands scrutiny of the underlying assumptions. What exactly are analysts modeling? How confident is the consensus? A forward P/E this low relative to trailing is a flag to dig deeper, not a green light.

When Trailing P/E Is More Reliable

For mature, stable businesses, trailing P/E is the more trustworthy number. A utility, a consumer staples company, or a financial with predictable earnings streams does not need a forward estimate to be understood. The trailing figure reflects actual performance across economic cycles.

Flowserve (FLS) is a reasonable example. Trailing P/E is 27.8x; forward P/E is 16.4x. The gap reflects margin expansion expectations from an activist-driven turnaround, not a revenue explosion. In this case, the forward estimate is doing real analytical work: it captures the operating leverage thesis. But the trailing multiple also tells you the stock is not cheap on current earnings, which is a useful constraint on enthusiasm.

When Forward P/E Can Mislead

Forward P/E is only as good as the estimates feeding it. Analyst consensus has a well-documented tendency to be optimistic, particularly for high-growth names. When a company misses estimates, the forward P/E recalculates upward instantly, and a stock that looked reasonably priced at 25x forward suddenly looks expensive at 40x forward on revised numbers.

C3.ai (AI) illustrates the risk from the other direction. Revenue fell 46.1% year-over-year, and no meaningful earnings figure is available. There is no reliable forward P/E to anchor valuation. The analyst consensus price target of $8.82 sits below the current price of $10.50. When the underlying business is deteriorating, forward estimates become speculative, and the P/E framework loses its grounding entirely.

How to Use Both Together

A practical framework:

• Large gap, high growth: The forward P/E is doing the heavy lifting. Verify that the growth assumptions are credible by checking revenue trends, margin trajectory, and analyst revision history.
• Small gap, stable business: Trailing P/E is the better anchor. Use it to compare against historical averages and sector peers.
• Forward P/E much higher than trailing: Earnings are expected to decline. Understand why before assuming the trailing multiple is cheap.
• No forward P/E available: The business is either pre-earnings or too volatile to model. Rely on revenue growth, gross margin, and cash flow instead.

The ratio between trailing and forward P/E is a compression or expansion signal. AVGO compressing from 94.5x to 26.3x tells you the market is pricing in a significant earnings step-up. SRPT compressing from 46.2x to 5.9x tells you analysts are modeling a binary outcome. TGT compressing from 16.4x to 14.0x tells you the recovery is expected to be gradual.

Reading the gap correctly is one of the fastest ways to understand what a stock's current price actually assumes about the future.